Guoqiang Pan

Immune microenvironment features and efficacy of <scp>PD‐1/PD‐L1</scp> blockade in non‐small cell lung cancer patients with <scp><i>EGFR</i></scp> or <scp><i>HER2</i></scp> exon 20 insertions

Kaiyan Chen, Guoqiang Pan, Guoping Cheng et al. · Thoracic Cancer · 2020 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Real‐world utilization of <scp>EGFR TKIs</scp> and prognostic factors for survival in <scp>EGFR</scp>‐mutated non‐small cell lung cancer patients with brain metastases

Xiaoqing Yu, Jiamin Sheng, Guoqiang Pan et al. · International Journal of Cancer · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy of <scp>PD</scp>‐1/<scp>PD‐L1</scp> inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in <scp>China</scp>

Jiamin Sheng, Hui Li, Xiaoqing Yu et al. · Thoracic Cancer · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

Xin‐Cheng Mao, Shuo Shi, Lun‐Jie Yan et al. · Biomarker Research · 2023 · 19 citations · Full text

Medicine, Oncology, Surgery +17

Ht31 peptide inhibited inflammatory pain by blocking NMDA receptor-mediated nociceptive transmission in spinal dorsal horn of mice

Wentao Wang, Guoqiang Pan, Ziyang Zhang et al. · Neuropharmacology · 2014 · 15 citations · Full text

Medicine, Neuroscience, Pharmacology +17